AcelRx Pharmaceuticals Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 54
Employees
  • Stock Symbol
  • ACRX
Stock Symbol
  • Share Price
  • $1.54
  • (As of Wednesday Closing)

AcelRx Pharmaceuticals General Information

Description

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The company has one approved product in the U.S., DSUVIA (sufentanil sublingual tablet) known as DZUVEO in Europe indicated for the management of acute pain, severe enough to require an opioid analgesic for adult patients and one product candidate, Zalviso (sufentanil sublingual tablet system) SST system being developed as an innovatively designed patient-controlled analgesia (PCA) system for the reduction of moderate-to-severe acute pain in medically supervised settings.

Contact Information

Website
www.acelrx.com
Formerly Known As
Surx
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 351 Galveston Drive
  • Redwood City, CA 94063
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AcelRx Pharmaceuticals Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.54 $1.42 $0.70 - $2.50 $128M 90.3M 1.66M -$0.56

AcelRx Pharmaceuticals Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 114,773 116,340 127,052 56,404
Revenue 5,153 2,289 2,151 7,995
EBITDA (44,725) (52,537) (35,152) (36,938)
Net Income (45,884) (53,240) (47,149) (51,508)
Total Assets 66,179 91,356 120,533 75,552
Total Debt 27,650 29,757 11,991 19,096
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AcelRx Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AcelRx Pharmaceuticals‘s full profile, request access.

Request a free trial

AcelRx Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore AcelRx Pharmaceuticals‘s full profile, request access.

Request a free trial

AcelRx Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of the
Pharmaceuticals
Redwood City, CA
54 As of 2020
00000
00000000 00000

00000 00

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
000000000000000
Solana Beach, CA
0 As of 0000
0000
00000000000 0000

00000 00

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p
000000000000000
Bridgewater, NJ
0000 As of 0000
00000
000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AcelRx Pharmaceuticals Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evoke Pharma Formerly VC-backed Solana Beach, CA 0 0000 00000000000 0000
00000 000000000000 Formerly VC-backed Bridgewater, NJ 0000 00000 000000&0
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
00000000 Venture Capital-Backed San Francisco, CA 0 0000 000000000 - 0000
000000 Formerly VC-backed Mountain View, CA 00 00000 000000&0 00000
You’re viewing 5 of 15 competitors. Get the full list »

AcelRx Pharmaceuticals Executive Team (18)

Name Title Board Seat Contact Info
Vincent Angotti Chief Executive Officer & Board Member
Raffi Asadorian Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Larry Hamel Chief Development Officer
Badri Dasu Executive
Pamela Palmer Ph.D Chief Medical Officer & Founder
You’re viewing 5 of 18 executive team members. Get the full list »

AcelRx Pharmaceuticals Board Members (11)

Name Representing Role Since
Adrian Adams Self Chairman & Board Member 000 0000
Howard Rosen AcelRx Pharmaceuticals Board Member 000 0000
Mark Edwards Self Board Member 000 0000
Mark Wan Three Arch Partners Board Member 000 0000
Richard Afable MD Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

AcelRx Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial